Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03924622 · ClinicalTrials.gov registry record · NA

Pressure Injury Prevention in AE and PFC

A NA study, sponsored by University of Washington.

Terminated
Registry status
NA
Development phase
72
Enrollment target

NCT03924622 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03924622, a NA study, was terminated before completion, sponsored by University of Washington.

TERMINATED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

This study evaluates the effect of a multilayer skin dressing (Mepilex) placed on the sacrum or a fluid filled pad (LiquiCell) on risk factors for pressure injuries under conditions consistent with military long-distance transport or prolonged field care. Participants will be assigned to one of six groups - air transport, air transport on a spinal immobilization surface with or without Mepilex or on a field stretcher with or without LiquiCell.

Interventions

  • DEVICE Mepilex
  • DEVICE LiquiCell

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2019-07-20
Est. Completion 2020-09-23
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT03924622

The ClinicalTrials.gov registry entry for NCT03924622 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mepilex is the first listed.

NCT03924622 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03924622 about?

NCT03924622 is a clinical study titled "Pressure Injury Prevention in AE and PFC". This study evaluates the effect of a multilayer skin dressing (Mepilex) placed on the sacrum or a fluid filled pad (LiquiCell) on risk factors for pressure injuries under conditions consistent with military long-distance transport or prolonged field care. Participants will be assigned to one of six ...

What is the current status of trial NCT03924622?

This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2019-07-20. Estimated completion is 2020-09-23.

What interventions are being tested in trial NCT03924622?

The interventions under investigation include: Mepilex (DEVICE), LiquiCell (DEVICE).

Who is sponsoring clinical trial NCT03924622?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.